Go Pro

iRadimed (IRMD) Earnings Date, Estimates & Call Transcripts

iRadimed logo
$86.95 0.00 (0.00%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$87.02 +0.08 (+0.09%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

iRadimed Earnings Summary

iRadimed issued Q2 2026 earnings on July 31, 2026, reporting an EPS of $0.46, which beat analysts' consensus estimates of $0.44 by $0.02. Quarterly revenue was reported to be $20.47 million, above the consensus estimate of $20.35 million. With a trailing EPS of $1.79 and a P/E Ratio of 48.58,

Upcoming Q3
Earnings Date
Nov. 2Before Market OpensEstimated
Consensus EPS
(Jul. 31)
$0.44
Actual EPS
(Jul. 31)
$0.46 Beat By $0.02
Actual Revenue
(Jul. 31)
$20.47M

Q2 2026 Earnings Resources

IRMD Upcoming Earnings

iRadimed's next earnings date is estimated for Monday, November 2, 2026, based on past reporting schedules.

Get iRadimed Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on iRadimed and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

IRMD Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

IRMD Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

iRadimed Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany EPS GuidanceCompany Revenue Guidance
Q2 20261$0.45$0.45$0.45$21.1 M0.440 - 0.480$20.0 M - $21.0 M
Q3 20261$0.51$0.51$0.51$23.7 M0.540 - 0.590$23.0 M - $24.5 M
Q4 20261$0.55$0.55$0.55

iRadimed Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/2/2026
(Estimated)
--------
7/31/2026Q2 2026$0.44$0.46+$0.02$0.41$20.35M$20.47M
5/1/2026Q1 2026$0.46$0.49+$0.03$0.45$21.32M$21.98M
2/10/2026Q4 2025$0.49$0.54+$0.05$0.50$21.60M$22.69M
11/3/2025Q3 2025$0.43$0.47+$0.04$0.43$20.50M$21.20M
2/13/2025Q4 2024$0.45$0.40 -$0.05$0.40$19.09M$19.39M
10/31/2024Q3 2024$0.36$0.40+$0.04$0.40$18.20M$18.33M

Earnings data for NASDAQ:IRMD is sourced from Fiscal.ai, with the most recent quarter reported on 7/31/2026. New results are added as companies report their earnings.
From Our Partners